ARCHIVES

Supreme Court Decision Means FTC Scrutiny As Costly Oncology Drugs Go Off-Patent

This article is from The Cancer Letter archive.

Vol. 39 No. 25 | June 21, 2013

Download PDF Visit The Full Archive

Related Articles

More Surgical Patients Die When Nurse Caseloads Rise

November 29, 2002

Loehrer To Direct IU Simon Cancer Center

March 5, 2010

Platinum-Free Break Enhances Therapy After First Relapse In Ovarian Cancer

March 28, 2003

PLCO Data Confirm Importance Of Regular Colorectal Cancer Screening, NCI Says

July 25, 2003

Seven New Initiatives For NIH Common Fund

February 26, 2010

ODAC Votes Against Adria’s Chemoprotector, Okays Leustatin

July 3, 1992